Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.56 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | MMP13 | P45452 | 2/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8022640 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL30424973 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL3932122 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL26969246 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL247523 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL2123672 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL11699305 | 1.00 | CA2 (0.56) | CA2CA1GPR84NFKB1CYP3A4 | |
| Potassium Ion SCHEMBL1133718 | 0.96 | CA2 (0.52) | CA2CA1GPR84NFKB1CYP3A4 | |
| Potassium Ion SCHEMBL1133667 | 0.96 | CA2 (0.52) | CA2CA1GPR84NFKB1CYP3A4 | |
| SCHEMBL5167672 | 0.89 | ZDHHC7 (0.47) | CA2CA1GPR84NFKB1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 848 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070120-A | Oral care compositions | 巴斯夫欧洲公司 | 2026-05-19 | — | — | CN | claimed |
| US-12593839-B2 | Fabric care composition comprising a mixture of cationic biocide, functionalized alkylpoyglycoside, and sulfolaurate salt | BROADOUS SR TIMOTHY (US) | 2026-04-07 | — | — | US | claimed |
| WO-2026041619-A1 | RINSE-FREE CLEANSING COMPOSITION | AHET LTD (GB) | 2026-02-26 | — | — | WO | claimed |
| WO-2025125362-A1 | SOLID GRANULAR MATERIAL FOR THE PREPARATION OF PERSONAL CARE PRODUCTS | BASF SE (DE) | 2025-06-19 | — | — | WO | claimed |
| WO-2025111227-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-05-30 | — | — | WO | claimed |
| CN-120022202-A | Personal care compositions | 高露洁-棕榄公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250161202-A1 | BIOME-FRIENDLY CONSUMER PRODUCTS | AOBIOME LLC (US) | 2025-05-22 | — | — | US | claimed |
| US-20250136901-A1 | BLENDS OF ALCOHOL ETHOXYLATE AND METHYL ESTER SULFONATE IN UNIT DOSE PRODUCTS FOR IMPROVED MILDNESS | HENKEL AG & CO. KGAA (DE) | 2025-05-01 | — | — | US | claimed |
| EP-4543547-A2 | DETOX HAIR AND SCALP CLEANSER COMPOSITION, METHODS AND USES THEREOF | K18, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| EP-4543406-A1 | HAIR CLEANSER COMPOSITION, METHODS AND USES THEREOF | K18, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| US-10111425-B2 | Disinfectant formulation | LABORATOIRE M2 (CA) | 2018-10-30 | — | — | US | claimed |
| US-20170142966-A1 | DISINFECTANT FORMULATION | LABORATOIRE M2 (CA) | 2017-05-25 | — | — | US | claimed |
| US-9609864-B2 | Disinfectant formulation | LABORATOIRE M2 (CA) | 2017-04-04 | — | — | US | claimed |
| US-9451763-B2 | Disinfectant formulation | LABORATOIRE M2 (CA) | 2016-09-27 | — | — | US | claimed |
| US-20160174550-A1 | DISINFECTANT FORMULATION | LABORATOIRE M2 (CA) | 2016-06-23 | — | — | US | claimed |
| US-20140142197-A1 | DISINFECTANT FORMULATION | LABORATOIRE M2 (CA) | 2014-05-22 | — | — | US | claimed |
| US-8637088-B2 | Natural silver disinfectant compositions | THE CLOROX COMPANY (US) | 2014-01-28 | — | — | US | claimed |
| WO-2013019969-A2 | HAIR CARE COMPOSITIONS | MELALEUCA, INC. (US) | 2013-02-07 | — | — | WO | claimed |
| US-20130034515-A1 | HAIR CARE COMPOSITIONS | MELALEUCA, INC. | 2013-02-07 | — | — | US | claimed |
| EP-1799963-B1 | METHODS AND AQUEOUS ACID SOLUTIONS FOR ACIDIZING WELLS CONTAINING SLUDGING AND EMULSIFYING OIL | HALLIBURTON ENERGY SERV INC (US) | 2012-10-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12593839-B2 | Fabric care composition comprising a mixture of cationic biocide, functionalized alkylpoyglycoside, and sulfolaurate salt | CUTA, MGAM, PLOD3 | CA2 1979/4885CA1 3023/4885GPR84 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.